Seborrheic Dermatitis Management

Introduction to Risk Factors

Patients with seborrheic blepharitis are highly likely to also have seborrheic dermatitis, with a co-occurrence rate of 95% 1, 2
Atopic dermatitis and psoriasis are associated with an increased risk of seborrheic dermatitis 2

Demodex mites may contribute to the development of seborrheic dermatitis in some cases, especially in older patients 2
Seborrheic dermatitis is characterized by follicular papules and pustules, greasy yellowish scaling, underlying erythema, itching, and discomfort, particularly on the scalp, in patients with the condition 3
The condition commonly affects sebum-rich areas of the body, including the scalp, face, ears, neck, chest, upper back, axillary folds, inframammary folds, and inguinal folds, as stated by the American Academy of Dermatology 3
Seborrheic dermatitis is more pronounced in patients with certain conditions, such as Down syndrome, HIV infection, and Parkinson's disease, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 4
The pathogenesis of seborrheic dermatitis is linked to Malassezia yeast proliferation, sebaceous gland activity, and immune dysregulation 3
Enhanced cell-mediated immunity to Malassezia has been detected in 40% of patients with chronic seborrheic dermatitis 1

Several conditions may mimic seborrheic dermatitis, including acute otitis externa (AOE), eczema (atopic dermatitis), psoriasis, contact dermatitis (both irritant and allergic), and discoid lupus erythematosus, as identified by the American Academy of Otolaryngology-Head and Neck Surgery 4
Misdiagnosis of conditions like psoriasis, atopic dermatitis, and tinea capitis, which can mimic seborrheic dermatitis, is also a common pitfall 5

Topical antifungal agents, such as ketoconazole cream or shampoo, ciclopirox, bifonazole, and selenium sulfide, are primary treatments for seborrheic dermatitis, recommended by the American Academy of Dermatology 3
Anti-inflammatory agents, including low-potency topical corticosteroids and topical calcineurin inhibitors, can be used for short-term treatment of seborrheic dermatitis, as suggested by the American Academy of Dermatology 3
Oral tetracyclines may be considered for grade 2+ inflammatory reactions in patients with seborrheic dermatitis and secondary bacterial infection 3
Appropriate antibiotics for Staphylococcus aureus superinfection may be used in patients with seborrheic dermatitis and folliculitis 3
Intralesional corticosteroid injections with triamcinolone acetonide (5-10 mg/mL) can be considered for patients with significant hair loss despite seborrheic dermatitis control, producing regrowth in a 0.5 cm diameter area, suitable for limited patches of hair loss, as recommended by the British Journal of Dermatology 6
Topical minoxidil may be considered for more extensive hair loss, though evidence is limited in the context of seborrheic dermatitis 6
Coal tar products, particularly for scalp involvement, are a treatment option for seborrheic dermatitis, as recommended by the American Academy of Dermatology 7

Regular use of antifungal products, gentle cleansing with pH-neutral formulations, and avoiding irritants and potential allergens can help manage seborrheic dermatitis, according to the American Academy of Dermatology 3
Maintenance therapy to prevent recurrence includes regular use of antifungal products and gentle cleansing with pH-neutral formulations, as suggested by Praxis Medical Insights 8
After initial control, transitioning to maintenance therapy with antifungal shampoo 1-2 times weekly and avoiding greasy hair products that may facilitate yeast growth is essential 9
For resistant cases, considering rotating between different antifungal agents to prevent resistance is crucial 5
To prevent recurrence of seborrheic dermatitis on the ear, it is recommended to keep ears dry, apply hypoallergenic moisturizing creams once daily, avoid inserting foreign objects into the ear canal, and consider acidifying ear drops after swimming if recurrent episodes occur, as advised by Praxis Medical Insights 8

Inadequate treatment duration, where antifungal treatments need to be continued for the full recommended course (typically 4 weeks for ketoconazole cream), is a common pitfall 9
Failure to address maintenance therapy, as seborrheic dermatitis is chronic and relapsing, requiring ongoing management, is also critical 9
The American Academy of Dermatology recommends avoiding the use of greasy topical products that can inhibit absorption of wound exudate and promote superinfection, as well as applying topical products shortly before radiation treatment for patients undergoing radiotherapy 3
The BMJ advises against prolonged use of potent topical corticosteroids on the scalp as they can potentially worsen hair loss over time 5